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1. Introduction 
Infertility is defined as the failure of a couple to become pregnant after one year of regular, 
unprotected, sexual intercourse. Misconceptions about infertility are very common. 
Infertility affects roughly 15% of all couples during their reproductive lives. Infertility is not 
"just a female problem" as there is a male infertility component in approximately 50% of 
couples. A couple experiencing infertility should not underestimate the significance of the 
problems that can exist in the male. Male infertility may be the sole contributing reason for 
the couple's failure to conceive and should be best identified by a male infertility specialist. 
According to the 2009 national summary report of the American Society for Assisted 
Reproductive Technology, nearly 35% of infertility is attributed to the male factor. In the late 
last century, treatment for severe male factor infertility was limited to inseminations or in 
vitro fertilization using donor sperm. However, most infertile couples, and particularly men, 
are reluctant to use donor sperm because of bias maintained across cultural and ethnic 
boundaries. Today, exciting advances in male infertility have introduced innovative 
therapeutic options, in particular, intracytoplasmic sperm injection (ICSI), which offers men, 
including those with no sperm (azoospermia) in their ejaculate due to genetic conditions, a 
greatly improved chance to conceive their own biological offspring (Palermo, et al.. 1992). 
Currently, despite severe male factor infertility, pregnancy may still be achieved. This is 
mainly attributed to the success of the ICSI technique and advanced surgical testicular 
sperm retrieval techniques. In recent years, the ICSI technique has evolved into 
intracytoplasmic morphologically selected sperm injection (IMSI) and a method for selection 
of hyaluronan bound sperm for use in ICSI (PICSI) (Parmegiani et al., 2010a,b; Said & Land 
2011; Berger et al., 2011), resulting in significantly increased fertilization and pregnancy 
rates over the world IVF clinics. Because the advanced ICSI technique in human IVF is 
covered in depth by other chapters of this book, the main emphasis here will be on the 
application of testicular biopsy sperm, round or elongated spermatids from azoospermic 
men to human IVF as well as explore new technologies to produce artificial sperm from 
stem cells and somatic cells. 
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2. Evaluation of male infertility-definition of azoospermia  
There are a variety of conditions that may lead to male infertility. An important component 
in the treatment of men with infertility is establishing the correct diagnosis through a 
thorough clinical evaluation of each couple. The cornerstone of the male fertility evaluation 
is the semen analysis, which is also the simplest evaluation for a male fertility. Complete 
evaluation of the infertile male involves a comprehensive medical history, physical 
examination and two and more semen analyses. 
In addition to semen analysis, specialized sperm function testing are available, including 
measurement of sperm capacitation and the acrosome reaction, computer assisted sperm 
motion analysis (CASA), sperm antibody testing, and leukocyte quantitation. According to 
the World Health Organization (WHO, 2010), the lower reference limit for semen 
characteristics should include a semen volume (1.4-1.7ml), sperm concentration (12-16 
million/ml), motility (38-42%), and morphology (3.0-4.0), as an integral screen of sperm 
fertilization potential. A persistently abnormal finding outside of the normal range often 
indicates male infertility. An abnormal semen analysis may be the first sign of significant 
pathology that may be life threatening in up to 1-2% of cases. The diagnosis of infertility 
may not only indicate a problem with the husband but also may put the health of his 
offspring at risk. With a growing understanding about the genetics of male infertility, a 
genetic cause may exist in up to 20% of patients. The primary goal of the evaluation is to 
determine the cause of the problem and to exclude life threatening pathology. Thus, genetic 
diagnosis of male infertility plays an important role in the application of assisted 
reproductive technology. Today, genetic testing for cystic fibrosis, Karyotyping and Y 
microdeletion analysis are important male infertility diagnostic tests for couples who are at 
risk of inherited genetic diseases. 
After detailed semen analysis, potential causes of male infertility may present (Comhaire & 
Vermenlen, 1995) as (1) complete absence of sperm (azoospermia), (2) low sperm count 
(oligozoospermia), (3) abnormal sperm shape (teratozoospermia), (4) problems with sperm 
movement (asthenozoospermia), (5) completely immobile sperm (necrozoospermia), where 
the sperm may be alive and not moving, or they may be dead (6) problems with sperm 
delivery, due to sexual dysfunction, an obstruction, previous vasectomy, or retrograde 
ejaculation. In an earlier generation of investigations, the most common cause of male 
infertility was reported to be the presence of a varicocele, which is the presence of a varicose 
vein found in the scrotum. The extra heat caused by the vein was suggested to lead to low 
sperm counts and impaired sperm movement. However, some clinical studies have failed to 
demonstrate a significant increase in pregnancy following varicocele repair. It is likely that 
genetic abnormalities noted in the modern studies of Y chromosomal micro-deletions account 
for abnormal parameters. With the development of intracytoplasmic sperm injection (ICSI) 
technology, a laboratory specialist uses microscopic tools to isolate a single sperm and then 
injects it directly into an egg. This technique, used in conjunction with in vitro fertilization 
(IVF), has been especially successful as a treatment for men who have a low sperm count 
(oligozoospermia), asthenozoospermia and women who have a small number of mature eggs. 
Also, oligozoospermic men often carry seminal populations demonstrating increased 
chromosomal aberrations and compromised DNA integrity. Therefore, the in vitro selection of 
sperm for ICSI is critical and directly influences the paternal contribution to preimplantation 
embryogenesis. Hyaluronan (H), a major constituent of the cumulus matrix, may play a critical 
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role in the selection of functionally competent sperm during in vivo fertilization (Parmegiani et 
al., 2010a). Hyaluronan bound sperm (HBS) exhibit decreased levels of cytoplasmic inclusions 
and residual histones, an increased expression of the HspA2 chaperone protein and a marked 
reduction in the incidence of chromosomal aneuploidy. The relationship between HBS and 
enhanced levels of developmental competence led to the current clinical trial (Worrilow et al., 
2010). Thus, as a HBS test, a PCISI technique, a method for selection of hyaluronan bound 
sperm for use in ICSI, has been developed to treat oligozoospermic and asthenozoospermic 
man infertility problem. Additionally, recently advanced IMSI technique has been used to 
treat sperm morphology problems (teratozoospermia). In cases of necrozoospermia, motile 
spermatozoa may be found by adding pentoxifylline or other chemicals such as 2-
deoxyadenosine to treat semen and sperm (Angelopoulos et al., 1999), or live sperm will be 
determined by hypo-osmotic swelling test (Takahashi et al., 1990).  
The most sever cases of male infertility are those presenting with no sperm in the ejaculate 
(azoospermia). Some men have a condition where their reproductive ducts may be absent or 
blocked (obstructive azoospermia or OA), where others may have no sperm production 
with normal reproductive anatomy (non-obstructive azoospermia or NOA). Azoospermia is 
found in 10% of male infertility cases. Patients with OA due to congenital bilateral absence 
of the vas deferens or those in whom reconstructive surgery fails have historically been 
considered infertile. Men who can not produce sperm in their testes with apparent absence 
of spermatogenesis diagnosed by testicular biopsy are classified as NOA. Once testicular 
and epidiymal function can be verified, surgery may be justified to correct or remove the 
blockage. Alternatively, the current optimal method for treatment of azoospermic men is to 
acquire sperm from the testis or epididymis by either non-surgical or surgical means. 
3. Acquiring sperm from azoospermic men 
For men with no sperm at all in their semen, sperm may be obtained by non-surgical or 
surgical techniques based on the complete evaluation and diagnosis of male factor infertility. 
3.1 Non-surgical sperm retrieval techniques 
3.1.1 Electro-ejaculation (EEJ) 
Many factors may predispose spinal cord injured men to infertility. Ejaculatory dysfunction, 
abnormalities of sperm production, chronic infections and blockage of sperm within the male 
reproductive tract are all potential factors. Currently a number of different methods have been 
used to obtain sperm from azoospermic men. For example, sperm can often be obtained 
through vibratory stimulation to the head and shaft of the penis. Men with ejaculatory failure 
due to nerve damage caused by spinal injury, and occasionally by other conditions, can 
produce sperm by electrical stimulation of the ejaculatory ducts internally. Electro-ejaculation 
or sperm harvesting along the ejaculatory path from the vas deferens, epididymis, and directly 
from the testis is a very successful form of therapy for men who have normal sperm 
production but can not ejaculate because of a short circuit in the nervous system. Though 
sperm quality is often poor due to remaining too long in the body, the sperm are usually 
suitable for ICSI treatment. EEJ has also proven effective for loss of ejaculation in patients with 
other conditions such as diabetes, retroperitoneal lymph node dissection, pelvic surgery, 
multiple sclerosis, or unexplained loss of orgasm. EEJ is non-invasive and patients routinely 
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return back to desk type work that day after a pain-free procedure of 30 minutes with local 
anesthesia at an outpatient surgery center. Electro-ejaculation allows the retrieval of sperm in 
more than 90% of patients, but in most of cases, sperm concentration and sperm motility is 
relatively low. Combining EEJ with current ICSI techniques, this may yield up to a 50% 
pregnancy rate. Overall, the chances for pregnancy in the informed and motivated patient are 
similar to those of a healthy male. However, electro-ejaculation must be performed under 
satisfactory anesthesia in men with spinal cord injuries with sensation in or below the 
abdomen. To avoid the complication of autonomic dysreflexia, a complete urologic 
examination must be performed prior to the procedure to detect and treat any urinary tract 
infections. Often during this procedure retrograde ejaculation occurs, which is a backwards 
ejaculation into the bladder, and sperm must be collected from the urine. 
3.1.2 Testicular sperm aspiration (TESA) and percutaneous epididymal sperm 
aspiration (PESA) 
TESA and PESA have been used as minimally invasive or non-surgical sperm aspiration 
techniques for use in conjuncture with assisted reproductive technology. This technique is a 
quick and painless procedure performed under sedation. A tiny percutaneous needle is 
used to extract sperm directly from the testis or epididymis. Using these minimally invasive 
techniques, sperm can be obtained from men with vasectomy, failed vasectomy reversal, 
absence of the vas deferens, or uncorrectable blockages anywhere along the seminal tract 
(obstructive azoospermia). In addition, individual sperm occasionally may be obtained in 
some cases of non-obstructive azoospermia (NOA). Sperm retrieval procedures are typically 
done at an outpatient surgery and last about one hour. The advantages of percutaneous 
aspiration techniques are that they can be performed with local anesthesia, without open 
scrotal exploration and its attendant postoperative discomfort, and without microsurgical 
expertise. Also it does not require hospitalization, and recovery is virtually immediate. 
Patients return back to desk type work in one or two days. It should be noted that for some 
men, a single percutaneous aspiration procedure may yield enough sperm to permit sperm 
freezing for several subsequent ICSI attempts. While the ejaculate normally contains 100 to 
300 million sperm, aspiration of as few as 100-200 sperm by this technique have been 
enough to achieve pregnancy when it is combined with ICSI. 
3.2 Surgical sperm retrieval techniques 
In cases where sperm production is low or there is some atrophy of testes or epididymis, 
microsurgical techniques known as Microscopic Epididymal Sperm Aspiration (MESA) and 
Testicular Sperm Extraction (TESE) can be used to obtain sperm from the epididymis, the 
sperm rich tube at the back of the testis, or removing small samples of testis tissue for 
processing and eventual extraction of sperm. These two techniques are more aggressive 
ways of recovering sperm. Microscopic TESE (MicroTESE) is a very exacting search for 
sperm under high magnification in cases of extremely low sperm production. MESA and 
TESE procedures are the most popular because the goal is retrieval of sufficient sperm for 
freezing and use in future ICSI cycles. MESA involves direct retrieval of spermatozoa from 
epididymal tubuli, thus it minimizes contamination of the epididymal fluid by blood cells, 
which may affect spermatozoa fertilizing capacity during IVF (Cornell Physicians, 2010). 
However, in the most clinical situations, the results of MESA are often poor and 
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unpredictable. Thus, testicular sperm extraction (TESE) is an effective method and a well 
accepted technique for sperm retrieval from men with non-obstructive azoospermia or 
obstructive azoospermia for ICSI. However, the conventional TESE technique requires 
multiple blind testis biopsies, with excision of large volumes (>700 mg) of testicular tissue 
and risks permanent damage to the testis. Recent research ((Pühse et al., 2011) has suggested 
that testicular biopsy is not necessary for diagnosis of OA because they have normal FSH 
and glucoside levels and normal testicular volumes. However, normal spermatogenesis 
often appears in the larger testis. Thus, the use of unilateral therapeutic biopsy in men with 
OA is feasible and the large side testicle should be operated on when there is a significant size 
difference between two testicles. Using optical magnification, a relatively avascular region of 
the testis is located for an incision. Currently, because many urology clinics do not have 
advanced micro-surgical instruments, testicular tissue is often removed from testis or 
epididymis by routine surgical biopsy. The testis is exposed and a long incision is made in the 
tunica to expose the testicular parenchyma. The seminiferous tubules are gently separated and 
examined under an operating microscope. Testicular sperm may be found within testicular 
tissue of many men with non-obstructive azoospermia. The optimal technique of sperm 
extraction would be minimally invasive and avoid destruction of testicular function without 
compromising the chance of retrieval adequate numbers of spermatozoa to perform ICSI. 
Since testicular biopsy is an invasive procedure, the efficient use of TESE would reduce 
surgical aspiration to single sperm retrieval by including cryopreservation. 
4. Optimal use of testicular biopsy sperm 
Surgical retrieval of testicular sperm for ICSI is now a widely practiced technique in the 
treatment of azoospermic men, but testicular biopsy is an invasive procedure. Thus, the 
optimal use of testicular biopsy tissue for patient treatment would reduce surgical extractions 
to retrieval of a single sample. In the last decade, many groups have suggested methods to 
optimize the use of testicular biopsy specimens. Several strategies have been developed to 
optimally manage a testicular biopsy, including improvement of sperm motility and 
increasing the motile sperm recovery rate after freezing (Wu et al., 2005). In most cases, only 
few spermatozoa can be obtained from minced testicular tissue and many of these free 
spermatozoa display complete immotility and occasionally only an individual sperm shows a 
slowly “twitching” movement. The goal of therapy is to obtain sufficient motile sperm from 
testicular biopsy tissue for use with ICSI to treat male infertility. In our clinical practice, we use 
the following three methods to optimize use of a single testicular biopsy specimen.  
4.1 Motile or non-motile sperm recovery from testicular biopsy tissue 
The surgical biopsy of testicular tissue is often carried out by an urologist under local 
anesthesia. After obtaining the testicular biopsy tissue (TESE), an examination for the 
presence of sperm and their motility should be immediately performed, but the TESE 
samples often contain a lot of tissue, red blood cells and debris. In our laboratory, after 
mincing and cutting the specimen into small pieces, all tissue and medium are transferred 
into a centrifuge tube and washed with modified modified human tubal fluid (mHTF) 
medium (Irvine scientific, CA) by centrifuge. After removing supernatant, the pellet is 
suspended again with 1-2 ml mHTF medium and mixed. After that, a slide with a small 
piece tissue is made to check for the presence of sperm under the microscope. 
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4.2 In vitro maturation of testicular biopsy tissue 
The only requirement for ICSI is one living spermatozoon per oocyte (Nagy et al., 1995). 
Sperm movement itself is not necessary for successful fertilization but it is the most 
reliable marker of viability. Although testicular sperm extraction is used frequently to 
obtain sufficient sperm for ICSI, very few spermatozoa demonstrate twitching motility or 
are completely immotile in the initial testicular biopsy samples. Our research observed 
less than 3% motile sperm (slight twitching) during the initial collection of testicular 
biopsy samples (Wu et al., 2005). In most cases, it is very difficult to find sufficient motile 
sperm in the initial or frozen-thawed TESE samples. Thus, our study indicated that 
culturing testicular biopsy tissue for a period has been a reliable method to obtain motile 
sperm with ICSI. In order to get more motile sperm from fresh or frozen-thawing 
testicular biopsy tissue, we conducted a comparative experiment with two culture 
medium, mHTF and HTF (Figure 1). 
Fresh TBX Frozen TBX
mHTFHTF HTF
Different Time Culture
1, 2, 3, 4, 5 days
5%CO2
37oC
5%CO2 
37oC
37oC
TBX PVP
ICSI dish 
oocyte
 
Fig. 1. Procedure for culture of testicular biopsy tissue in two media (mHTF and HTF). 
Minced tissues were divided into two parts and were cultured in HTF with CO2 incubation 
or mHTF without CO2 incubation. After one to 5 days of culture, motile sperm numbers 
were compared.  
Our result indicates that either fresh or frozen-thawing testicular biopsy tissue is cultured 
slightly better in HTF medium under 5% CO2 at 37oC than in mHTF medium at 37oC, but 
there was no significant difference (Table 1). Our further experiment showed that after 24 
hour in vitro culture, the number of motile sperm increases remarkably, with a maximum 
motility rate seen between 48-72 hours of culture (Figure 2). Motile spermatozoa still are 
observed up to 120 hours in culture (Wu et al., 2005). Based on our research and clinical 
practice, it appears that the optimal time for ICSI using testicular sperm is after 24-48 
hours of culture. This may allow the testicular biopsy procedure to be performed 1 or 2 
days before oocyte retrieval and provides flexibility in scheduling these procedures in 
clinical practice. 
www.intechopen.com
 Advances in Fertility Options of Azoospermic Men 
 
121 
Culture Time  0 hr 24 hrs 48 hrs 72 hrs 96 hrs 120 hrs 
HTF medium 2.1 ±2 9.0±7.2 15.0±6.5 35.0±15.3 25.4 ±11 15.0±9.3 
mHTF medium 2.0±2 7.5±6.5 12.0±7.6 31.0 ±17.2 23.0±12 13.0 ±9.9 
Note: At 0 hour, the initial motile sperm from collecting biopsy tissue just display twitching tail. After 
culture, some movement sperm were observed at different time. Motile sperm numbers in HTF medium 
are slightly higher than in mHTF medium, but there is no significant statistic difference (P>0.05). 
Table 1. Effect of in vitro culture of testicular tissue in two media on sperm motility  
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Fig. 2. Effect of in vitro culture time of TESE on sperm motility. 
4.3 Cryopreservation of testicular biopsy tissue 
Open surgical testicular biopsy is an invasive intervention. Cryopreservation of the 
testicular biopsy specimen can avoid repeated testicular biopsies in azoospermic patients in 
whom the only source of spermatozoa is the biopsy. Cryopreservation of testicular sperm 
using a simple freezing protocol is promising in patients with obstructive and non-
obstructive azoospermia augmenting the overall success achieved after surgical sperm 
retrieval (Friedle et al., 1997). Also, when the frozen-thawed testicular spermatozoa were 
cultured for 48 hours, sperm motility showed a significant improvement (Figure 2). Our 
studies indicate that frozen-thawed TESE specimen displayed similar motility to fresh TESE 
samples during in vitro culture. After 24 hours of culture, frozen-thawed TESE samples also 
showed an increased number of motile sperm. We did not observed a significant 
detrimental effect of freezing on testicular sperm survival in most specimens. However, we 
did observe freezing damage to other cells including spermatids and germ cells. The 
freezing protocol using test yolk buffer containing glycerol (Irvine Scientific, Santa Ana, CA) 
is simple, practical and provides reliable sperm survival. We therefore would recommend 
cryopreservation of all testicular biopsy specimens routinely in IVF clinical practice. 
In summary, freezing and in vitro maturation culture of testicular biopsy specimens are 
useful approaches to the management of testicular biopsy samples from both obstructive 
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and non-obstructive azoospermic patients. These techniques offer the possibility of several 
attempts at IVF/ICSI from single testicular biopsy sample. One to three days of in vitro 
culture for fresh and frozen samples before an oocyte retrieval may increase the availability 
of motile spermatozoa for ICSI. Testicular biopsy freezing and subsequent culture may be a 
reliable alternative for patients to undergo testicular biopsy surgery prior to oocyte retrieval, 
allowing for flexibility in scheduling patients for clinical procedures. 
5. Treatment for globozoospermia 
Globozoospermia, found in <0.1% of infertile male patients, results in the inability of the 
sperm to fertilize an oocyte. Globozoospermia is an uncommon sperm disorder associated 
with infertility and is also a severe form of teratozoospermia, characterized by round-headed 
sperm with an absence of acrosome vesicles and a disorganization of the midpiece and tail 
(Holstein et al. 1973). Sigh et al., (1992) described different types of globozoospermia with 100% 
affected sperm or only partial teratozoospermia and complete lack of acrosome and spherical 
nucleus or with some remains of acrosome vesicles detached from the nucleus. Transmission 
electron micrographs of spermatozoon from a globozoospermic man demonstrate the typical 
round head, large vacuolated regions within the nucleus, absence of acrosome and an 
abnormal mid-piece and tail (Stone et al., 2000, Dam et al., 2007).  Nuclear damage was also 
described with abnormal chromatin packaging (Larson et al., 2001) and mitochondria 
abnormalities (Battaglia et al., 1997). Morphological defects in human sperm cells raise 
suspicion for further anomalies within the sperm cell and could have implications in clinical 
practice. Recently, Dam et al., (2007) reviewed and summarized the phenotypic 
manifestations, and possible causes of the condition as well as implications for clinical practice 
of globozoospermia, as a prerequisite for genetic analysis. In globozoospermia, there is an 
absence of acrosomal structures leading to absence of spermatozoa binding to the zone 
pellucida. Thus, ICSI is an only treatment option for these patients, but poor fertilization and 
only few baby births have been reported since the first live-birth from globozoospermia was 
reported in 1995 (Trokoudes et al., 1995). This poor fertilization rate can probably be explained 
by abnormal oocyte activation (Battaglia et al., 1997; Nardo et al., 2002). Low fertilization rates 
after ICSI indicate that these sperm do not have an ability to activate the oocyte. Thus, various 
oocyte activation methods including conventional ICSI sucking ooplasm or calcium ionophore 
have been used with some pregnancies and live births have been reported (Rybouchkin et al., 
1996; Eldar-Geva, et al., 2003). However, some cases have reported normal live-births after 
intracytoplasmic sperm injection for globozoospermia without assisted oocyte activation 
(Stone et al., 2000; Banker et al., 2009). Generally speaking, the use of the ICSI technique in 
conjuncture oocyte activation may allow the globozoospermic patient to realize their dream to 
have a baby, however low fertilization and pregnancy rates seriously influence the overall 
success. Also, the use of these sperm does not appear to increase abortion, miscarriage rates or 
aneuploid / birth defects in the offspring of such men (Dam et al. 2007). Currently in clinical 
IVF practice, the only treatment option in these cases is ICSI, although repeated treatment 
cycles can be performed and no apparent predictors of success have been identified. 
6. Selection of spermatids  
In some azoospermic men, even though extensive surgical techniques such as 
microepididymal sperm aspiration (MESA), fine needle aspiration (FNA), testicular sperm 
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extraction (TESE) and testicular sperm aspiration (TESA) have been used, no spermatozoa 
can be found. Thus, many attempts have been made to develop new techniques of assisted 
fertilization using immature male germ cells. Some studies have showed that spermatids 
can be efficiently used as substitute gametes because of their high fertilizing ability 
comparable with that of mature sperm (Al-Hasani et al, 1999; Mansour et al., 2003). This 
technique is an exciting breakthrough in treatment of the infertile man with azoospermia. 
Spermatids are immature haploid germ cells that have not yet undergone the biochemical 
and morphological changes that accompany spermiogenesis through to the formation of 
spermatozoa. Morphologically, the shaping of the mammalian sperm involves the 
elongation and condensation of the spermatid nucleus, the development of the acrosome, 
and the transient appearance of the microtubular manchette, thus spermatids may display 
round or elongate shapes (Kierszenbaum et al., 2007). The elongating and elongated 
spermatids seem to have an advanced development compared with round spermatids. At 
this developmental stage, the elongating spermatids are easy to recognize among the other 
cell types in a wet preparation (Figure 3). Men with non-obstructive azoospermia can be 
treated by using intra-oocyte round spermatid injection (ROSI) or elongated spermatid 
injection (ELSI). It has been suggested that spermatids should be injected intact and that 
elongated spermatids are preferred to round spermatids where possible (Fishel, 1995). 
Spermatids can be retrieved from semen or from testis biopsy tissue before the final stage of 
spermatogenesis and the formation of sperm (Figure 3). The nucleus of these cells contains 
half the number of the chromosomes, thus may be injected directly into oocytes. The 
fertilization rate was not different between round and elongated spermatids, although the 
fertilization rates for round and elongated spermatids in the ejaculate were 33 and 18% 
respectively, compared with 22 and 38% respectively when testicular spermatids were 
utilized (Fishel et al., 1997). However, multiple comparisons have shown that spermatozoa 
and elongated spermatids gave better implantation and birth rates than did round 
spermatids, while spermatozoa and elongated spermatozoa were indistinguishable in their 
ability to support embryonic development (Ogonuki et al., 2010). Since the first baby was 
born as a result of spermatid injection (Tesarik et al., 1995), many healthy babies have been 
born using spermatid injection. In the past few years, our IVF center has injected round 
spermatids to five patients’ oocytes and a health boy was born in 2007. A typical case was 
that 6 oocytes were retrieved from a 23 age woman and only 4 matured oocytes were 
injected with her husband’s round spermatids from fresh testicular biopsy tissue in April 
2006. One egg displayed normal two pronuclei and another egg was abnormal three 
pronuclei. Other two were unfertilized oocytes. On day 3, only normal fertilized embryo at 
6-cell stage was transferred and finally a boy was born in February of 2007. Our clinical 
practice provides experienced diagnosis that when normal living spermatozoa or elongated 
spermatids cannot be found in the testicular biopsy specimen, round spermatids can be used 
successfully and result in the delivery of healthy offspring. However, the fertilization rate 
with round spermatid injection is relative low and only young couples may be good 
candidates successful for pregnancy. 
Although spermatids may be used in azoospermic patients as a treatment option for their 
infertility, its efficiency is questionable because low fertilization and pregnancy rates 
influence seriously its success (Sousa et al., 1998; Akhondi et al., 2003). One major question 
facing spermatid use may be associated with problems related to incomplete nuclear protein 
maturation. Accordingly, many investigators are interested in spermatid in vitro culture and  
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Fig. 3. Spermatids and global sperm in the testicular biopsy tissue. Figure A and B indicate 
unstained testicular biopsy tissue and red and yellow arrows indicate elongated and round 
spermatids, respectively. White arrow indicates a spermatozoon. The round cells are blood 
cells. Figure C and D are stained slides with Testsimplets®. Global sperm without tail could 
be observed (C) and spermatids and a spermatozoon were seen in D.  
an attempt to find the appropriate medium that could successfully mature round 
spermatids up to the elongated stage in vitro or even to mature spermatozoa at a 
reasonable rate (Cremades et al., 1999). Also, the research on in vitro culturing of round 
spermatids should study the optimum temperature for maturation, the reason why 
spermatogenesis in vitro seems accelerated, and whether the whole spermatogenic 
population can be used instead of isolated cells (Tesarik et al., 2000; Amarin et al, 2002). In 
our TESE culture experiments, a few round spermatids displayed a slight shape changes 
after 24 to 48 hour culture, but we can not determine whether this culture may promote 
round spermatids to become elongated spermatids because we did not track individual 
spermatid growth. Although some reports indicated that round spermatids can develop 
flagellum and elongate after in vitro culture under special media (Aslam and Fishel, 1999), 
we suggest that selecting optimally shaped spermatids without membrane damage for 
oocyte injection seems to be an important factor in achieving fertilization. In spite of the 
fact that in vitro culture of round spermatids is a promising approach, we recommend that 
before using in vitro matured spermatids for clinical trials, these cells should be firstly 
examined to verify if they are viable (Trypan Blue exclusion staining), if they contain 
normal chromosomal [fluorescent in-situ hybridization (FISH)], if they are able to fertilize 
oocytes (experimental injections and determination of normal fertilization and cleavage 
rates), and if the embryos produced are genetically normal by FISH. Injection of a live 
spermatid into an oocyte will increase the fertilization opportunity, but identification of a 
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live spermatid is difficult. Thus, choosing optimally shaped cells may be helpful in 
distinguishing live spermatids from most cells in testicular biopsy specimens by simply 
respecting the criteria of cell size and detecting the presence of a round nucleus 
surrounded by a rim of cytoplasm in wet preparations with Hoffman optics (Figure 3; 
Silber et al., 2000).  
As described above, spermatids have a nuclear protein immature statue, but activated 
oocyte cytoplasm may induce nuclear protein maturation after injecting spermatid to oocyte 
intracytoplasm. Thus, oocyte activation is very important for spermatid injection. Oocytes 
can be activated before or during injection in order to destroy maturation promoting factor 
(MPF) by various artificial treatments such as physically vigorous ooplasmic aspiration 
during injection, electrical pulses and injection of oscillin, and chemically calcium 
ionophores or ethanol stimulation. In fact, treatment of spermatid injected oocytes with 
inophore A 23187 has been shown the increase of the fertilization rate and has resulted in 
the birth of a healthy child with ROSI (Ahmady & Michael 2007). Based on our clinic 
practice, we suggest that the spermatid membrane should be broken by injection pipette 
when it is placed in oocyte cytoplasm without other oocyte activation. A round spermatid is 
7-8µm in diameter and has a round shape with smooth outlines. When these spermatids are 
selected for injection into an oocyte, a same size (7-8µm) pipette in inner diameter may be 
used. Using this technique, the spermatid is aspirated into the pipette and the spermatid 
membrane can be broken by pipette squeezing when it is pushed out of the pipette. This 
simple technique may greatly increase spermatid fertilization.  
7. Use of secondary spermatocytes  
Round or elongated cytoplasmic spermatid injection can result in the delivery of normal 
offspring in human IVF, but it is sometimes difficult to distinguish Hoffman optics whether 
they are haploid round spermatids, diploid spermatocytes, spermatogonia, or even somatic 
cells like Sertoli cell nuclei or Leydig cells. Can we consider the use of immature 
spermatogenic germ cells for fertilization? Based on our understanding of the oocyte 
maturation mechanism, oocyte maturation arrests at the meiosis II stage because the 
mammalian oocyte contains two key factors: metaphase-promoting factor (MPF) and 
cytostatic factor (CSF), in which the c-Mos proto-oncoprotein is a major component (Wu et 
al, 1997a,b). These two key factors are active in the oocyte cytoplasm and maintain the 
chromosomes of mature oocytes in metaphase of the second meiotic division. When the 
oocyte is activated by the above-mentioned methods, the degradation of c-Mos onco-protein 
causes CSF and MPF inactivity in the cytoplasm and the chromosomes of injected spermatid 
or spermatozoon as well as the oocyte begin condensation, which leads to halploidization of 
both chromosome sets and forms formal fertilized zygotes. However, when immature 
diploid spermatocytes are injected into oocytes, oocyte activation should be absent. Thus, 
the injected cell nucleus is exposed to MPF and CSF environment in which MPF and CSF 
may induce injected cell nucleus to enter metaphase stage as the same way as does the 
oocyte nucleus. (Tesarik, 1996). If the oocyte is activated, the disappearance of MPF and CSF 
activity will lead the injected cell nucleus to undergo condensation and to complete meiosis 
and form a haploid chromosome set. Thus, the premature chromosome condensation of 
injected cells occurring in the absence of oocyte activation is essential for achieving 
fertilization with secondary spermataocytes (Kimura and Yanagimachi 1995). 
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8. Adult somatic cell induction 
Using the same theory and technique, somatic cells also may be induced into a haploid 
chromosome set by immature or mature oocytes (Tesarik 2002; Keefer 2007; Neri et al., 2009) 
because some important materials of germinal vesicle oocyte is essential for cell nucleus 
remodeling (Gao et al., 2002). In our preliminary animal experiments, a bovine cumulus cell 
from ovary follicular fluid was injected into an enucleated oocyte. After 24 hour in vitro 
culture, injected cell nuclei were stained by Hoechst 33258 and two separated chromosome 
sets were observed using fluorescence microscopy (Figure 4A). After two sets of 
chromosome were taken out by manipulation, their chromosome numbers were counted. 
Adult cattle have 60 diploid chromosomes. After induction, each set contains 30 
chromosomes (Figure 4B and 4C). Thus, the immature oocyte can induce successfully 
somatic cells to become haploid. When the haploid nucleus is moved out of the induced 
matured oocyte and transferred into a normal female oocyte, using electro-fusion activation, 
both the oocyte nucleus and the injected male nucleus begin condensation to form a similar 
zygote which develops into an embryo for transfer (Figure 5).   
 
Fig. 4. Preliminary experiments of using an oocyte to induce somatic cell chromosomes into 
a haploid chromosome set. A single bovine cumulus cell was injected into an enucleated 
immature oocyte. After 24 hour in vitro culture, injected cell nuclei were stained by Hoechst 
33258 and two chromosome sets were observed using fluorescence microscopy (blue color, 
A). After each chromosome set was separated by manipulation, 30 chromosomes were 
counted in each set (green color, B and C). Authors greatly appreciate Dr. Bin Wang’s 
courtesy unpublished photos. 
A 
B
C
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Fig. 5. Scenario for using immature oocytes to induce male somatic cell complete meiosis. 
The nucleus of the immature oocyte is removed and a male diploid cell was injected into the 
enucleated oocyte. After completing meiotic division, the induced haploid nucleus was 
transferred into a normal female mature oocyte to form a biparental embryo for transfer.   
9. Sperm cell cloning 
In some men with oligozoospermia and azoospermia, occasionally a single viable sperm 
may be found in their semen and/or testicular biopsy tissue. Therefore, such a sperm is 
precious to couples wishing to conceive. How can this single sperm be utilized to help 
patients realize their dream of having a baby? If only one sperm is found, we must be 
reluctant to use it for anything but fertilization. As described above, because the cytoplasm 
of oocyte may induce heterogonous cell nucleus condensation, we may try to inject a sperm 
into an enucleated oocyte to observe sperm nucleus kinetics (Jones et al., 2010; Ogonuki et 
al., 2010). Recent studies demonstrated possibility of artificially replicating a single sperm 
genome, which could help men with very low sperm counts become fathers. This is called 
“cloning of sperm cells or male genome cloning” (Figure 6). With this technique it should be 
possible to create enough sperm nuclei to ensure that produced and implanted embryo is 
healthy. The cloning of sperm cells has been practiced on mice by injecting a mouse sperm 
into a mouse oocyte which had its nucleus removed (Hopkin, 2007). The sperm may form a 
single male pronucleus in this enucleated oocyte by egg activation and electrofused. The 
haploid zygote may become cleaved embryos. When the resulting embryo develops to 4 to 8 
cells, each blastomere may be separated by a specific solution (Figure 6). The process 
worked well in almost all cases and the produced blastomere from original sperm was 
found to be chromosomally identical to its originator in over 80% of the clones analyzed. 
Then, the resulting cells were fused with a normal egg that had been previously chemically 
activated. Based on this technique, Dr. Palermo’s research group created 64 blastocyst 
embryos and implanted them into 6 host mother mice resulting in only 4 developed into 
normal baby mice (Takeuchi et al., 2008). This offspring born as a result of such replication had 
shown a level of abnormalities consistent with that shown in cloned animals. This technique 
provides a new hope for azoospermic men to have a child, but we are a long way from the 
time when this will be able to be used in humans (Takeuchi et al., 2008). There is much work 
still needed to be done to understand why impaired development and abnormalities in the 
embryo occur, and to take steps to avoid that occurrence (Neri et al., 2009). 
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Fig. 6. Scenario for sperm genome cloning. A single sperm is injected into enucleated oocyte 
and this oocyte goes through a parthenogenesis process to become a 4-8 cell haploid 
embryo. A single blastomere is transferred into a normal mature oocyte to form a zygote. 
The developed embryos are transferred to recipient mice to deliver offspring.  
10. Artificial sperm production  
Development of embryo stem cell technology has resulted in a breakthrough for artificial 
sperm production (Ogawa, 2008). In the last decade, many research groups have attempted 
to re-create the process of sperm production in the laboratory using stem cells as the starting 
material, especially using mice as an animal model. In 2003, American scientists successfully 
coaxed embryonic stem cells from mice to mature into primitive sperm, which were then 
injected into eggs to form normal embryos. This “artificial sperm” capable of fertilizing an 
egg has been created in the laboratory for the first time in an experiment that could bring an 
end to male infertility. In 2005, British scientists took a step towards showing that the 
human egg and sperm could be created from stem cells and in 2009, this human sperm have 
been created from stem cells in world first from British university (Alleyne, 2009). This is the 
first time human sperm has been created anywhere in the world in a laboratory. However, 
the experiment has proved controversial, threatening to reopen the fierce debate over 
embryo research. Recently, Japanese researchers were able to turn mouse embryonic stem 
cells into early sperm cells called primordial germ cells (PGCs) and successfully implanted 
early sperm cells which were made from the stem cells into infertile mice, which after the 
treatment were able to produce healthy offspring (Hayashi et al., 2011).  
The procedure of artificial sperm production was successfully repeated using another type 
of embryonic cell that was manipulated into a stem cell state. These stem cells are known as 
induced pluripotent stem (iPS) cells and have previously been created from a variety of 
different starting cells, including skin cells. Male embryonic stem cells with green protein 
makers may be selected and extracted from mouse embryos. These embryonic stem cells are 
a type of cell that has the ability to differentiate into any of the specialized cell types that 
make up the body. Under a given condition, the embryonic stem cells are induced to develop 
SrCl2
MII 
Inject a sperm
Haploid 
blastomere 
Normal MII
Biparental embryo 
Zygote
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into a particular type of cell, called “primordial germ cell-like cells or PGCs”. Primordial germ 
cells go on to form germ cells, which then produce sperm. Then the primordial germ cell-like 
cells were transplanted into the testes of mice that lacked their own germ cells. When these 
cells develop into sperm, they may be extracted from testes and injected into normal mouse 
oocytes. The embryos produced were transferred into female mice so that healthy offspring 
were born. This study has huge implications for furthering our understanding of how sperm 
are made, but may also one day lead to a clinical application whereby we could make sperm 
for infertile men. In next ten years, we believe that this technique could also be used to allow 
infertile couples without any sperm and spermatids to have children that are genetically their 
own. It could even be possible to create sperm from female stem cells, which would ultimately 
mean a woman having a baby without a man. 
11. Conclusions 
Exciting advances in male infertility have introduced innovative therapeutic options. This is 
mainly attributed to the success of the ICSI technique rapidly gaining popularity among 
infertile couples and advanced surgical testicular sperm retrieval techniques in azoospermic 
men, which offer infertile couples, including those with no sperm (azoospermia) in their 
ejaculate due to genetic conditions, a greatly improved chance to conceive their own 
biological offspring. Currently, despite severe male factor infertility, pregnancy may still be 
achieved by current developed technology. As the ICSI technique further improves, a single 
good morphologic and functional spermatozoon may be selected by IMSI or PICSI methods 
and an improved embryo implantation and pregnancy rate will be obtained. Testicular 
biopsy seems to be one of the most feasible techniques obtaining spermatozoa for 
azoospermic men because a single biopsy of testis may provide either spermatozoa if the 
specimen contains sperm or spermatids if biopsy tissues do not contain any sperm for ICSI. 
Using testis biopsy sperm for azoospermia may gain the same high pregnancy rate as the 
normal ejaculation sperm, but efficiency of spermatid application is doubted because low 
fertilization and pregnancy rates influence seriously its success. As cell cloning technology 
develops, other options for treatment of azoospermic men include use of secondary 
spermataocytes, sperm cell cloning, and artificial sperm production by inducing stem cells 
and adult somatic cells into sperm cells. Although these technologies still remain at animal 
research stage and demonstrate a low efficiency, we believe that application of these novel 
techniques will greatly improve chance for infertile couples (particular azoospermic men) to 
conceive their own biological offspring in the next decade. 
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